<DOC>
	<DOCNO>NCT00546052</DOCNO>
	<brief_summary>To determine one year treatment Losartan without HCTZ different dosage effect metabolic parameter patient hypertension metabolic syndrome .</brief_summary>
	<brief_title>A 52 Week Study Evaluate Effects Losartan With Without HCTZ Plasma Glucose , Metabolic Parameters , Blood Pressure Hypertensive Patients With Metabolic Syndrome ( 0954A-331 )</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>An Adult Patient ( At Least 18 Years Of Age ) With A Clinical Identification Of The Metabolic Syndrome Using The IDF Definition : abdominal ( central ) obesity define waist circumference men &gt; 102 cm woman &gt; 88 cm BMI equal great 30 kg/m2 untreated hypertension bp equal great 140/90 mm Hg bp &lt; 180/110 mm Hg patient receive one two antihypertensive agent ( ) ( diuretic , ace inhibitor , angiotensin ii receptor blocker , calcium channel blocker betablockers need discontinue ) whose blood pressure control : bp equal great 140/90 mm Hg equal less 160/100 mm Hg patient whose hypertension control ( &lt; 140/90 mm hg ) single antihypertensive agent ( diuretic , ace inhibitor , angiotensin II receptor blocker , calcium channel blocker betablockers need discontinue ) unsatisfied experience side effect warrant discontinuation previous treatment one following : Fasting plasma glucose equal great 5.6 mmol/L &lt; 7.0 mmol/L Triglycerides &gt; 1.7 mmol/L specific treatment lipid abnormality HDLc men &lt; 0.9 mmol/L woman &lt; 1.1 mmol/L specific treatment lipid abnormality A Patient With A Diagnosis Of Type II Diabetes Defined As Fasting Blood Glucose Level Equal Or Greater Than 7.0 Mmol/L Or A 2hpg In A 75G OGTT Equal Or Greater Than 11.1 Mol/L Or Using Any AntiHyperglycemic Agents Known Secondary Hypertension Of Any Aetiology ( E.G. , Uncorrected Renal Artery Stenosis , Malignant Hypertension , Or Hypertensive Encephalopathy ) Patient Intolerant To Any Component Of Losartan 50 Mg / Losartan 100 Mg / Losartan 100 Mg + Hctz 12.5 Mg / Losartan 100 Mg + Hctz 25 Mg Or With A Documented History Of Angioedema Patient With Confirmed Clinically Significant Renal Or Hepatic Dysfunction And/Or Electrolyte Imbalance On The Basis Of The Case History Or A Recent Laboratory Test ( Serum Creatinine &gt; 130 Mmol/L Or Creatinine Clearance &lt; 45 Ml/Min , Ast &gt; 2 Times Above The Normal Range , Alt &gt; 2 Times Above The Normal Range , Serum Potassium &lt; 3.5 Or &gt; 5.5 Meq/L ) Patient With Symptomatic Heart Failure ( Classes 3 And 4 ) Patient With A Prior Myocardial Infarction Or Stroke Within The Last 6 Months Patient Who Has Undergone Percutaneous Coronary Angioplasty Or Coronary Artery Bypass Within The Last 3 Months Pregnant Woman Or A Woman Of Childbearing Potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>